|
|
|
Volumn 27, Issue 3 SUPPL. 5, 2000, Pages 32-36
|
|
Long-term outcome following treatment of hairy cell leukemia with pentostatin (Nipent): A National Cancer Institute of Canada study
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
CLADRIBINE;
PENTOSTATIN;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
IMMUNOSUPPRESSIVE AGENT;
ADULT;
AGED;
BONE MARROW BIOPSY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG EFFICACY;
FEMALE;
FOLLOW UP;
HAIRY CELL LEUKEMIA;
HUMAN;
LEUKEMIA REMISSION;
MALE;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RELAPSE;
TREATMENT OUTCOME;
ARTICLE;
CANADA;
CAUSE OF DEATH;
INTRAVENOUS DRUG ADMINISTRATION;
LONGITUDINAL STUDY;
MIDDLE AGED;
MULTICENTER STUDY;
PATHOLOGY;
REMISSION;
SECOND CANCER;
SURVIVAL RATE;
TUMOR RECURRENCE;
ADULT;
AGED;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC AGENTS;
CANADA;
CAUSE OF DEATH;
CLADRIBINE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INJECTIONS, INTRAVENOUS;
INTERFERON-ALPHA;
LEUKEMIA, HAIRY CELL;
LONGITUDINAL STUDIES;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASMS, SECOND PRIMARY;
PENTOSTATIN;
REMISSION INDUCTION;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 0033919638
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (42)
|
|
References (27)
|
